IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Swiss health-care group Galenica to split into two listed companies

9:33 AM MDT | August 12, 2014 | Natasha Alperowicz

Galenica (Bern, Switzerland) said today that it is adapting a new management structure. The group will be headed by two CEOs, one in charge of Vifor Pharma, formerly the pharma division, and one of Gelenica Santé, the former Santé division. Both CEOs will report directly to the executive chairman. The role of CEO Galenica Group is being abolished. With this move, the board is creating the best conditions for both the Vifor Pharma and Galenica Santé units to prepare to become listed, independent companies when the time is right, the company...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa